CVS HEALTH CORPORATION Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination
CVS HEALTH CORPORATION (CVS) reported Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination of $109.00 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Notes
us-gaap:ContractWithCustomerLiabilityIncreaseDecreaseForContractAcquiredInBusinessCombination · last filed 2024-02-07
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-12-31 was $0.00.
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-09-30 was $5.00M.
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-06-30 was $36.00M.
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for the quarter ending 2023-03-31 was $68.00M.
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2023 was $109.00M.
- CVS HEALTH CORPORATION contract with customer, liability, increase (decrease) for contract acquired in business combination for fiscal 2022 was $0.00.
| Period end | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 3 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 6 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 9 month | Contract with Customer, Liability, Increase (Decrease) for Contract Acquired in Business Combination 12 month |
|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $5.00M derived: sum of 2 quarters · filed 2024-02-07 | $41.00M derived: sum of 3 quarters · filed 2024-02-07 | $109.00M 10-K · filed 2024-02-07 |
| 2023-09-30 | $5.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $41.00M derived: sum of 2 quarters · filed 2023-11-01 | $109.00M 10-Q · filed 2023-11-01 | $109.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2023-06-30 | $36.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $104.00M 10-Q · filed 2023-08-02 | $104.00M derived: sum of 3 quarters · filed 2024-02-07 | $104.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2023-03-31 | $68.00M 10-Q · filed 2023-05-03 | $68.00M derived: sum of 2 quarters · filed 2024-02-07 | $68.00M derived: sum of 3 quarters · filed 2024-02-07 | $68.00M derived: sum of 4 quarters · filed 2024-02-07 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $0.00 derived: sum of 2 quarters · filed 2024-02-07 | $0.00 derived: sum of 3 quarters · filed 2024-02-07 | $0.00 10-K · filed 2024-02-07 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $0.00 derived: sum of 2 quarters · filed 2023-11-01 | $0.00 10-Q · filed 2023-11-01 | |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PETMED EXPRESS INC (PETS) | United States | $0.034B | -1.41 |